International Journal of Clinical Research

Objective To explore the clinical efficacy and practical value of levothyroxine in the treatment of subclinical hypothyroidism. Methods 80 subclinical hypothyroidism patients admitted to our hospital from October 2022 to October 2023 were selected as the study subjects. Patients were randomly divided into a control group (40 cases, treated with conventional therapy) and a study group (40 cases, treated with levothyroxine) according to different treatment methods. Compare and analyze the levels of blood lipid indicators and treatment outcomes between two groups of patients. Results Both groups of patients achieved certain results after treatment. The total effectiveness of treatment in the study group was higher than that in the control group, with lower levels of TC, TG, and LDL-C compared to the control group. There was no significant difference in HDL-C levels compared to the control group. Conclusion The treatment of subclinical hypothyroidism with levothyroxine has significant clinical effects, can effectively improve the level of blood lipid indicators in patients, enhance the treatment effect of patients, and has high safety and clinical application value.

Levothyroxine; Subclinical hypothyroidism; Treatment effects